MBRX vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

MBRX

38.8
AI Score
VS
CLYM Wins

CLYM

50.9
AI Score

Investment Advisor Scores

MBRX

39score
Recommendation
SELL

CLYM

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric MBRX CLYM Winner
Net Income 33.56M -27.22M MBRX
Operating Income -25.10M -30.57M MBRX
ROE 223.6% -11.4% MBRX
ROA 151.7% -11.1% MBRX
Total Assets 22.13M 246.29M CLYM
Cash 8.88M 44.11M CLYM
Current Ratio 1.41 31.45 CLYM

Relative Price Performance (Last 90 Days)

MBRX 1M: -29.9% · 3M: -79.7% CLYM 1M: -27.3% · 3M: -17.6%

Current Technical Phase

MBRX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -50.5%), weak momentum, RSI 35

RSI (14): 34.8 · Price: $0.49

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $10.94

Fundamentals Snapshot

Metric MBRX CLYM
Market Cap — —
Forward P/E -0.4 -10.9
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS 15.18 -0.79
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.